UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)

Complexity (New York, N.Y.), 2020, Vol.2020 (2020), p.1-8

2020

Volltextzugriff (PDF)

Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis

Complexity (New York, N.Y.), 2020, Vol.2020 (2020), p.1-6

2020

Volltextzugriff (PDF)

Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database

Sarcoma, 2022-04, Vol.2022, p.5815875-13

2022

Volltextzugriff (PDF)

Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma

Complexity (New York, N.Y.), 2020, Vol.2020 (2020), p.1-6

2020

Volltextzugriff (PDF)

Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer

Cancer, 2011-08, Vol.117 (16), p.3774-3780

2011

Volltextzugriff (PDF)

Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion

Therapeutic Advances in Medical Oncology, 2020-01, Vol.12, p.1758835919895756-1758835919895756

Chu, Quincy S.

2020

Volltextzugriff (PDF)

Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy

Cancer, 2011-04, Vol.117 (8), p.1775-1782

2011

Volltextzugriff (PDF)

How Is Receptor Activator of Nuclear Factor-κβ/Receptor Activator of Nuclear Factor-κβ Ligand Targeting Ranked as an Immuno-Oncology Target for NSCLC: a Pathway Unclear as yet?

Journal of thoracic oncology, 2020-10, Vol.15 (10), p.1561-1564

Chu, Quincy S.C.

2020

Volltextzugriff (PDF)

Present and Emerging Biomarkers in Immunotherapy for Metastatic Non-Small Cell Lung Cancer: A Review

Current oncology (Toronto), 2022-01, Vol.29 (2), p.479-489

2022

Volltextzugriff (PDF)

Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution

Complexity (New York, N.Y.), 2018, Vol.2018 (2018), p.1-7

2018

Volltextzugriff (PDF)

Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France

Complexity (New York, N.Y.), 2018, Vol.2018 (2018), p.1-13

2018

Volltextzugriff (PDF)

Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC

Current oncology (Toronto), 2023-07, Vol.30 (7), p.6473-6496

2023

Volltextzugriff (PDF)

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

Current oncology (Toronto), 2023-06, Vol.30 (7), p.6289-6315

2023

Volltextzugriff (PDF)

Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1676-1688

2016

Volltextzugriff (PDF)

Profiling Determinants of Resting Energy Expenditure in Colorectal Cancer

Nutrition and cancer, 2020-04, Vol.72 (3), p.431-438

2020

Volltextzugriff (PDF)

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer

Current oncology (Toronto), 2022-07, Vol.29 (7), p.4981-4997

2022

Volltextzugriff (PDF)

UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib

Cancer chemotherapy and pharmacology, 2009-12, Vol.65 (1), p.1-4

2009

Volltextzugriff (PDF)

Canadian Consensus Recommendations on the Management of MET -Altered NSCLC

Current oncology (Toronto), 2021-11, Vol.28 (6), p.4552-4576

2021

Volltextzugriff (PDF)

Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors

Clinical cancer research, 2022-01, Vol.28 (1), p.95-105

2022

Volltextzugriff (PDF)

Determinants of change in resting energy expenditure in patients with stage III/IV colorectal cancer

Clinical nutrition (Edinburgh, Scotland), 2020-01, Vol.39 (1), p.134-140

2020

Volltextzugriff (PDF)

Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors

Investigational new drugs, 2021-08, Vol.39 (4), p.1001-1010

2021

Volltextzugriff (PDF)

Impact of Adjuvant Atezolizumab on Recurrences Avoided and Treatment Cost Savings for Patients with Stage II-IIIA Non-Small Cell Lung Cancer in Canada

Current oncology (Toronto), 2024-06, Vol.31 (6), p.3301-3310

2024

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(144)

Publikationsform

Sprache

Englisch
(154)
Japanisch
(11)
Deutsch
(1)
Serbian
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(98)
Life Sciences & Biomedicine
(95)
Oncology
(82)
Humans
(75)
Male
(52)
Female
(51)
Middle Aged
(50)
Aged
(45)
Adult
(30)
Lung Neoplasms - Drug Therapy
(30)
Patients
(29)
Tumors
(28)
Chemotherapy
(25)
Lung Cancer
(23)
Biological And Medical Sciences
(22)
Cancer
(21)
Medical Sciences
(21)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(19)
Neoplasms - Drug Therapy
(19)
Aged, 80 And Over
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(21)
Sarcoma
(13)
Clinical Cancer Research
(11)
Current Oncology
(10)
Cancer Research
(8)
Complexity
(8)
Investigational New Drugs
(7)
Journal Of Thoracic Oncology
(7)
Cancer Chemotherapy And Pharmacology
(4)
Clinical Lung Cancer
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)

Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis

Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database

Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma

Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer

Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion

Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy

How Is Receptor Activator of Nuclear Factor-κβ/Receptor Activator of Nuclear Factor-κβ Ligand Targeting Ranked as an Immuno-Oncology Target for NSCLC: a Pathway Unclear as yet?

Present and Emerging Biomarkers in Immunotherapy for Metastatic Non-Small Cell Lung Cancer: A Review

Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution

Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and France

Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

Profiling Determinants of Resting Energy Expenditure in Colorectal Cancer

Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer

UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib

Canadian Consensus Recommendations on the Management of MET -Altered NSCLC

Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors

Determinants of change in resting energy expenditure in patients with stage III/IV colorectal cancer

Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors

Impact of Adjuvant Atezolizumab on Recurrences Avoided and Treatment Cost Savings for Patients with Stage II-IIIA Non-Small Cell Lung Cancer in Canada

Suchergebnisse filtern